A detailed history of Arlington Trust CO LLC transactions in Grifols Sa stock. As of the latest transaction made, Arlington Trust CO LLC holds 95 shares of GRFS stock, worth $842. This represents 0.0% of its overall portfolio holdings.

Number of Shares
95
Holding current value
$842
% of portfolio
0.0%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Jul 08, 2025

BUY
$6.49 - $9.09 $616 - $863
95 New
95 $0

Others Institutions Holding GRFS

About Grifols SA


  • Ticker GRFS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 678,910,976
  • Market Cap $6.02B
  • Description
  • Grifols, S.A. engages in the procurement, manufacture, preparation, and sale of therapeutic products, primarily hemoderivatives. The company operates through Bioscience, Hospital, Diagnostic, Bio Supplies, and Others divisions. The Bioscience division researches, develops, produces, and markets plasma-derived medicines and other innovative solut...
More about GRFS
Track This Portfolio

Track Arlington Trust CO LLC Portfolio

Follow Arlington Trust CO LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Arlington Trust CO LLC, based on Form 13F filings with the SEC.

News

Stay updated on Arlington Trust CO LLC with notifications on news.